Enacted as part of the 2021 Consolidated Appropriations Act, a new transparency provision now requires employer-sponsored health plans and health insurance issuers to submit information about prescription drugs and healthcare spending to the federal government on an annual basis. This reporting process is referred to as the “prescription drug data collection” (or RxDC report).
The first RxDC report is due by Dec. 27, 2022, and covers data for the 2020 and 2021 reference years. Subsequent reports are due June 1 every year after.
Download the bulletin to learn how the RxDC reporting requirement impacts employers, access reporting instructions, and identify next steps for your organization. For questions on your organization’s specific reporting process, please contact Plante Moran Group Benefit Advisors.
